Advanced Medical Optics (EYE)

ADVANCED MEDICAL OPTICS TO ACQUIRE INTRALASE CORP.

(SANTA ANA, CA), January 8, 2007 – Advanced Medical Optics, Inc. (AMO) [NYSE: EYE], a global ophthalmic surgical and eye care products company, and IntraLase Corp. [Nasdaq: ILSE], today announced that the two companies have entered into a definitive agreement for AMO to acquire IntraLase for approximately $808 million in cash.

Under terms of the agreement, approved by the boards of directors of both companies, following the receipt of fairness opinions from their respective financial advisors, AMO will pay $25 in cash per share of IntraLase stock and the individually determined cash value per share of outstanding stock options. AMO has arranged committed financing from a consortium of banks to complete the transaction. AMO expects the transaction to be completed early in the second quarter of 2007. The transaction is subject to IntraLase stockholder approval as well as regulatory approvals and other customary closing conditions.

“This acquisition offers significant strategic value by further establishing AMO as the global refractive technology leader, positioning us with a broad range of technologies and expertise to serve the needs of comprehensive refractive practices,” said AMO Chairman, President and CEO Jim Mazzo. “We believe the transaction benefits eye care practitioners and their patients by bringing together state-of-the-art technologies to define a new standard of care in laser vision correction.   Additionally, we believe the transaction is financially attractive and will create significant operating leverage and growth opportunities, as well as stockholder value.”

“Besides the value that we believe will be created for both companies’ stockholders, we think this transaction provides truly unique opportunities,” commented IntraLase President and CEO Robert J. Palmisano.  “There will now be the ability to advance our femtosecond laser technology in a coordinated way, both developmentally and commercially, with the world’s leading excimer laser technology. Also, this combination provides the opportunity for further innovation and beneficial refinement of LASIK procedures that can and should grow the overall LASIK market.” Mr. Palmisano concluded, “I am confident that this combination will provide for better surgical procedures for patients, happier customers and future opportunities for employees.”